CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Rocket Pharmaceuticals, Inc.  (ITEK)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Rocket Pharmaceuticals's Quick Ratio

ITEK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth



Select the Comparisons : Select the Ratio:                        

ITEK Quick Ratio (Mar 31 2018)
I. Quarter
(Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
Y / Y Current Liabilities Change -33.97 % -36.63 % -1.35 % 14.17 % 74.16 %
Y / Y Cash & cash equivalent Change 44.46 % -25.05 % 10.72 % 12.16 % 13.65 %
Quick Ratio MRQ 38.37 27.38 27.08 21.77 17.54
Overall Ranking # # # # #
Seq. Current Liabilities Change 26.41 % -6.2 % -23.77 % -26.96 % 21.33 %
Seq. Cash & cash equivalent Change 77.16 % -5.18 % -5.19 % -9.3 % -8.08 %



Quick Ratio first quarter 2018 Comment
Rocket Pharmaceuticals's Cash & cash equivalent grew by 77.16 % in I. Quarter sequntially, faster than Current Liabilities, this led to improvement in Rocket Pharmaceuticals's Quick Ratio to 38.37, Quick Ratio remained below Rocket Pharmaceuticals, Inc. average.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Quick Ratio than Rocket Pharmaceuticals in first quarter 2018. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ITEK Segments?
See Quick Ratio ITEK on the trailing twelve month basis
Quick Ratio first quarter 2018 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 9
Overall Market # 77


Quick Ratio Statistics
High Average Low
38.37 25.55 17.54
(Mar 31 2018)   (Dec 31 2016)


You need to upgrade your Flash Player


Financial Statements
Rocket Pharmaceuticals's Current Liabilities $ 5 Millions Visit ITEK's Balance sheet
Rocket Pharmaceuticals's Cash & cash equivalent $ 183 Millions Visit ITEK's Balance sheet
Source of ITEK's Sales Visit ITEK's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2018, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2018 MRQ Cash & cash equivalentMar 31 2018 MRQ Current Liabilities
Medicinova Inc  52.49 $ 62.939  Millions$ 1.199  Millions
Corvus Pharmaceuticals, Inc.  41.14 $ 143.933  Millions$ 3.499  Millions
Rocket Pharmaceuticals, Inc.  38.37 $ 182.697  Millions$ 4.762  Millions
Endocyte Inc  37.53 $ 173.125  Millions$ 4.613  Millions
Achillion Pharmaceuticals Inc  37.34 $ 303.864  Millions$ 8.138  Millions
Xencor Inc  34.73 $ 462.410  Millions$ 13.313  Millions
Madrigal Pharmaceuticals, Inc.  29.05 $ 182.825  Millions$ 6.294  Millions
Marinus Pharmaceuticals Inc  29.00 $ 52.020  Millions$ 1.794  Millions
Sage Therapeutics, Inc.  28.61 $ 1,083.513  Millions$ 37.872  Millions
Catalyst Pharmaceuticals, Inc.  28.54 $ 77.943  Millions$ 2.731  Millions
Glycomimetics Inc  27.91 $ 242.684  Millions$ 8.696  Millions
Albireo Pharma, Inc.  26.96 $ 192.916  Millions$ 7.156  Millions
Alpine Immune Sciences, Inc.  26.18 $ 76.652  Millions$ 2.928  Millions
Sierra Oncology, Inc.  23.74 $ 133.829  Millions$ 5.638  Millions
Ritter Pharmaceuticals Inc  23.61 $ 18.917  Millions$ 0.801  Millions
Global Blood Therapeutics, Inc.  22.69 $ 543.586  Millions$ 23.960  Millions
Intra-cellular Therapies, Inc.  22.24 $ 437.006  Millions$ 19.653  Millions
Versartis, Inc.  21.13 $ 74.686  Millions$ 3.535  Millions
Apellis Pharmaceuticals, Inc.  20.96 $ 152.931  Millions$ 7.295  Millions
Immune Design Corp.  20.61 $ 130.878  Millions$ 6.351  Millions
Geron Corp  20.54 $ 90.048  Millions$ 4.385  Millions
Abeona Therapeutics Inc.  20.45 $ 131.995  Millions$ 6.454  Millions
Prophase Labs, Inc.  19.74 $ 21.714  Millions$ 1.100  Millions
Insmed Inc  19.73 $ 686.581  Millions$ 34.806  Millions
Arena Pharmaceuticals Inc,  18.55 $ 629.121  Millions$ 33.911  Millions
Ophthotech Corp.  18.28 $ 154.911  Millions$ 8.474  Millions
Kindred Biosciences, Inc.  18.16 $ 70.824  Millions$ 3.899  Millions
Synlogic, Inc.  17.95 $ 125.803  Millions$ 7.010  Millions
Chimerix Inc  17.83 $ 160.447  Millions$ 9.001  Millions
Arbutus Biopharma Corp  16.60 $ 172.540  Millions$ 10.396  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NTIP's Profile

Stock Price

NTIP's Financials

Business Description

Fundamentals

Charts & Quotes

NTIP's News

Suppliers

NTIP's Competitors

Customers & Markets

Economic Indicators

NTIP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071